Weekly round-up #223

A Vaccine for Leprosy?

A Vaccine for Leprosy?

Yesterday VALIDATE held the third in its successful "A Vaccine for...?" seminar series. 40 people, including VALIDATE members and guests, gathered on Zoom to hear Dr Khushboo Borah provide a background about Leprosy, the disease caused by Mycobacteria Leprae of which there are still over 200,000 new cases diagnosed every year. Dr Chyntia Carolina Díaz Acosta then explored mechanisms of Schwann cells modulation by M. leprae with emphasis on host lipid metabolism. 

These seminars provided were aimed at vaccine researchers who do not study the pathogen and were part of VALIDATE's commitment to fostering an exchange of ideas and cross-pathogen collaboration.

You can watch a "Vaccine for Leishmaniasis?" right now and we will upload the seminars on Melioidosis and Leprosy on the VALIDATE YouTube Channel soon. 


  • MRC Clinical research training fellowship - Apply for funding to undertake a PhD or to reacquire research skills. Your research can focus on any area of MRC’s remit to improve human health - deadline: 22 July 2022
  • Wellcome Discovery Awards - This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing - deadline 26 July 2022
  • Innovate UK Smart Grants - Opportunity for UK registered organisations to apply for a share of up to £25 million from Innovate UK to deliver disruptive R&D innovations that can significantly impact the UK economy - deadline 27 July 2022
  • MRC Applied global health research - Funding to support research that will benefit the health of vulnerable global populations - Deadline 28 July 2022
  • The British Academy: Researchers at Risk Fellowships – Funding establishing a Researchers at Risk Fellowships Programme with the support of the Academy of Medical Sciences, the Royal Academy of Engineering and the Royal Society - deadline 29 July 2022

You can find a list of all relevant external funding we've spotted for our members on our external funding page.​​​​ ​​

Training Opportunities and Events:

Find more training and events opportunities on our Training and Events pages.

Job Opportunities:

More relevant career opportunities on our jobs page.


Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.


Highlights on Twitter this week:

There is a new initiative to develop a new TB vaccine in Indonesia, a study suggests TB bacteria can adapt rapidly to new environments (also mentioned here), and the Global Vaccine Demand Event discussed engaging communities and enhancing vaccine confidence. Healthline discussed the link between TB and HIV, IAVI discussed the importance of African researchers, and we promoted our “A Vaccine for Leprosy?” seminar. eLife shared an interesting 3d animation of a transpeptidase enzyme binding site, GAVI discussed the potential of a “universal test and treat” for TB and HIV. Author John Green asked his followers what they thought was the deadliest non-COVID disease in the world (with interesting results, Rachel Tanner thanked us for giving her a chance to present in the ECR Summer Showcase, and GSK announced an £8 billion investment in NTD research in LMICs. The BSI discussed the importance of childhood vaccinations and the British Science Association is looking for researchers to take part in their Community Buddies scheme. Precision Vaccination asked if a BCG Vaccine can protect HIV-Positive Children and the European Pharmaceutical review discussed philanthropic ventures in fighting tropical diseases (including leishmaniasis). Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.


Published: 29 June 2022